The MarketWatch News Department was not involved in the creation of this content. CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gene ...
Pfizer PFE and partner BioNTech BNTX announced that a phase III study evaluating an mRNA-based combination vaccine candidate against influenza and COVID-19 missed one of its two primary immunogenicity ...
NEW YORK (Reuters) - Pfizer Inc's experimental pill for rheumatoid arthritis appeared to be effective and well-tolerated in a mid-stage clinical study, the drugmaker said. The drug, known as ...
A Pfizer drug recently awarded accelerated FDA approval in colorectal cancer now has additional data showing it met key goals in its pivotal study, results that could support an application seeking ...
Pfizer Inc ((PFE)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
AARP has launched a new research initiative, called Project Catalyst, where the organization will work with partners including Pfizer, UnitedHealthcare, and Georgia Tech to promote an increased focus ...
"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice ® and integrated ADC platforms to deliver innovative cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results